Related Experiment Video
Updated: Aug 7, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
[Lipids--diagnosis and therapy in type 2 diabetes]
1Medizinische Universitätsklinik Graz, Graz, Osterreich. thomas.wascher@meduni-graz.at
Abstract:
Hyper- and Dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy with statins has convincingly proved to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the use of lipid-lowering drugs in diabetic patients according to current scientific evidence.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

